
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Intrinsic Value
The intrinsic value of one
Shanghai HeartCare Medical Technology Corp Ltd
stock under the Base Case scenario is
26.11
HKD.
Compared to the current market price of 26.45 HKD,
Shanghai HeartCare Medical Technology Corp Ltd
is
Overvalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Shanghai HeartCare Medical Technology Corp Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Shanghai HeartCare Medical Technology Corp Ltd
Balance Sheet Decomposition
Shanghai HeartCare Medical Technology Corp Ltd
Current Assets | 1B |
Cash & Short-Term Investments | 713.7m |
Receivables | 94.7m |
Other Current Assets | 215.4m |
Non-Current Assets | 182.5m |
Long-Term Investments | 9.5m |
PP&E | 117.8m |
Intangibles | 43.3m |
Other Non-Current Assets | 11.9m |
Free Cash Flow Analysis
Shanghai HeartCare Medical Technology Corp Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Shanghai HeartCare Medical Technology Corp Ltd
Revenue
|
277.9m
CNY
|
Cost of Revenue
|
-96.2m
CNY
|
Gross Profit
|
181.7m
CNY
|
Operating Expenses
|
-196.3m
CNY
|
Operating Income
|
-14.6m
CNY
|
Other Expenses
|
988k
CNY
|
Net Income
|
-13.6m
CNY
|
Profitability Score
Profitability Due Diligence
Shanghai HeartCare Medical Technology Corp Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Score
Shanghai HeartCare Medical Technology Corp Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai HeartCare Medical Technology Corp Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Shanghai HeartCare Medical Technology Corp Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai HeartCare Medical Technology Corp Ltd
According to Wall Street analysts, the average 1-year price target for
Shanghai HeartCare Medical Technology Corp Ltd
is 20.4 HKD
with a low forecast of 20.2 HKD and a high forecast of 21 HKD.
Dividends
Current shareholder yield for Shanghai HeartCare Medical Technology Corp Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Shanghai HeartCare Medical Technology Corp Ltd
stock under the Base Case scenario is
26.11
HKD.
Compared to the current market price of 26.45 HKD,
Shanghai HeartCare Medical Technology Corp Ltd
is
Overvalued by 1%.